Background: Laparoscopic upper abdominal surgery can cause spontaneous respiration due to diaphragmatic stimulation and intra-abdominal CO2 inflation. Therefore, sufficient muscle relaxation is necessary for a safe surgical environment.
INTRODUCTION
Since laparoscopic upper abdominal surgery can cause spontaneous respiration due to diaphragmatic stimulation and intra-abdominal CO2 inflation, neuromuscular monitoring and the administration of a non-depolarizing muscle relaxant during surgery are required [1] [2] [3] [4] [5] [6] . Cisatracurium, in comparison with rocuronium, has a delayed onset and a longer duration of action, which can lengthen post-operative recovery. However, rocuronium can cause an overdose of its muscle relaxant effect due to repetitive additional injections [7] [8] [9] [10] . Based on the findings of previous studies,
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Lifestyle Medicine rocuronium has a faster onset time and faster spontaneous T1 and train-of-four recovery (TOF) time compared with cisatracurium, and the combination of the half equipotent dose of rocuronium and cisatracurium causes synergistic interaction [11] [12] [13] . In this study, we investigated if the combination of rocuronium and cisatracurium can complement the delayed onset of cisatracurium's action and the delayed recovery of muscle relaxation and whether the dosage of rocuronium can be reduced. Patients allergic to medication used in the research, patients with renal disease or radiculopathy, patients who were pregnant or breast-feeding, patients using antipsychotic medication or neuroleptics, and patients using medication that affects succinylcholine chloride were all excluded [16] .
MATERIALS AND METHODS
Computerized randomization was used for double blinding; a resident who did not participate in the anesthesia transferred the previously set dosage of a neuromuscular blocker to a scale-covered syringe according to a random number table and included this numbering in the case report form.
A nurse who did not participate in the study transferred the test agents and the case report form to a researcher.
Prior to surgery, patient height and body weight were with systolic blood pressure ＜90 mmHg, phenylephrine 50 mcg IV was injected, while in hypertensive cases, with systolic blood pressure ＞200 mmHg, nicardipine 250 mcg was administered [17] . Even if the T1/T4 ratio was less than 25%, an additional rescue dose was intravenously injected in cases of unanticipated movement of respiratory muscles.
The three groups were statistically compared using the Chi-square test, Fisher's exact test, and one-way ANOVA.
For post-hoc tests after one-way ANOVA, the Tukey method was used. Based on a preliminary study, the number of patients required for each group to achieve a power of 0.9
and type I error of 0.05 was 22; therefore, 25 patients in total were required for each group accounting for a withdrawal rate of 10%. All data were expressed as mean ± standard deviation or number, and statistical significance was accepted at p ＜ 0.05. *There are significant differences between the three groups in post-analysis using Turkey's method. Values are mean ± SD. 
RESULTS
This study investigated 75 patients who underwent laparoscopic cholecystectomy between September 2014 and March 2015. There was no statistically significant difference in age or gender between the three study groups.
However, there was a significant difference in ASA classification (p = 0.022) and BMI (p = 0.036) between the groups (Table 1) .
There was no significant difference in blood pressure or pulse rate before and after anesthesia, body temperature, peripheral arterial O2 saturation, operation and anesthetic durations, or recovery index between the three groups.
However, the onset time in Group C, 25% duration in Group duration, and addition/time ratio are presented in Table 2 and Fig. 1 . which is unaffected by hepatic metabolism, is administered, the onset time of the muscle relaxant can be delayed and prolonged [19, 25] .
Repetitive injection of rocuronium can complicate the pharmacokinetic prediction of residual or prolonged post-operative muscle relaxation because its effect may be prolonged in diseases causing biliary tract obstruction [20, 22] . Therefore, for patients with diseases causing biliary tract obstruction, objective neuromuscular monitoring and anti-cholinesterase drugs or sugammadex administration are required to reduce residual muscle relaxation and respiratory complications [16, 26, 27] . However, sugammadex is still utilized in this country, although limitedly due its high cost [28, 29] . This study was performed in order to find a solution to these issues and to examine whether the prolonged effect of muscle relaxation is adequately applied to the operation duration when rocuronium is injected in combina- In this study, there was no spontaneous respiration or movement recorded. There was also no reduction of O2 saturation (＜90%) in pulse oximetry after surgery. This is assumed to be due to the injection of additional muscle relaxants upon constant monitoring of muscle relaxation status.
This study performed TIVA using propofol and remifentanil in order to exclude the potentiating effect of muscle relaxation caused by inhalation anesthetics [7, 8, 10, 18] . In addition, after the initial measurement of body temperature prior to anesthesia, body temperature was maintained at 36.0 ± 0.5℃ using a forced-air warmer in order to prevent a change in the duration of muscle relaxation due to body temperature change [30] . It was also verified that there was no significant difference between groups by measuring blood pressure, as well as the pulse rate, before and after anesthesia induction [17] . Furthermore, the target concentration of propofol was adjusted to maintain the anesthetic depth with BIS 35-55, and the end-tidal CO2 pressure was adjusted to 35-40 mmHg in order to reduce pH change due to hyperventilation or laparoscopic CO2 inflation [5, 16] .
This study has a few limitations. First, pre-and post-operative comparative assessments of liver function, which can affect the metabolism of rocuronium, were not performed.
This factor can affect the residual muscle relaxation effect of rocuronium. These assessments were not performed be- For TOF ratio ≥90% during the recovery of muscle relaxation, glycopyrrolate 0.2 mg and pyridostigmine 10 mg were injected; however the TOF ratio was not measured in the post-anesthetic care unit. Therefore, the objective evaluation of residual muscle relaxation could not be performed and was alternatively evaluated using the reduction of O2 saturation or respiratory distress expressed by the patient.
Consequently, the discrepancy in residual muscle relaxation among the three groups was not verified. It is necessary to perform further studies comparing the effects of combined muscle relaxants injection according to liver function and residual muscle relaxation.
In conclusion, during laparoscopic cholecystectomy, the injection of the ED95 of rocuronium and cisatracurium can provide a more suitable muscle relaxation effect than the injection of intubating doses of rocuronium or cisatracurium alone.
